PROJECT

Projects

Summary of Investment Information

Project Number

38257

Company Name

ASCENDIS HEALTH LIMITED

Date SPI Disclosed

May 24, 2016

Country

South Africa

Region

Africa

Projected Board Date

May 4, 2016

Environmental Category

B - Limited

Status

Completed

Last Updated Date

Feb 26, 2025

Department

Regional Industry - MAS ME & Africa

Industry

Health, Education and Life Sciences

Previous Events

Approved : May 4, 2016
Signed : May 11, 2016
Invested : Aug 18, 2016

Sector

Other Medical

Project Description

The project consists of an equity investment of up to US$30 million in Ascendis Health Limited (“Ascendis” or the “Company”), a publicly listed South African based pharmaceutical, medical device and consumer brands company. The project will provide the Company with funding to finance the acquisitions of (i) 100% of Remedica, a generic pharmaceutical brands company; and (ii) 100% of Scitec, a leading sports nutrition company that owns one of the top three brands in Europe.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation